Oxidative damage to DNA of ovarian surface epithelial cells affected by ovulation: Carcinogenic implication and chemoprevention

Experimental Biology and Medicine

Volumn 229, Issue 6, 2004, Pages 546-552

  Murdoch, William J ^a   Martinchick, James F ^b  

^a UNIVERSITY OF WYOMING   (United States)

^b Ivinson Memorial Hospital   (United States)

Author keywords

Epithelial ovarian cancer; Ovulation; Oxidative DNA damage; Vitamin E

Indexed keywords

8 HYDROXYGUANINE; ALPHA TOCOPHEROL; ANTIOXIDANT; POLYSORBATE 80; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EARLY DIAGNOSIS; EPITHELIUM CELL; HUMAN; NONHUMAN; OVARY CANCER; OVARY CELL; OVARY FOLLICLE; OVULATION; OXIDATIVE STRESS; PROTEIN SYNTHESIS; SHEEP; WOUND HEALING;

ANIMALIA; FALLOPIA; OVIS; OVIS ARIES;

EID: 2942594342     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422900613     Document Type: Article

References (65)

1. Espey LL. Ultrastructure of the apex of the rabbit Graafian follicle during the ovulatory process. Endocrinology 81:267-276, 1967.
2. Papadaki L, Beilby JOW. The fine structure of the surface epithelium of the human ovary. J Cell Sci 8:445-465, 1971.
3. Bjersing L, Cajander S. Ovulation and the role of the ovarian epithelium. Experentia 31:605-608, 1975.
4. Anderson E, Lee G, Letourneau R, Albertini DF, Meller SM. Cytological observations of the ovarian epithelium in mammals during the reproductive cycle. J Morphol 150:135-166, 1976.
5. Espey LL. Ovulation as an inflammatory reaction - a hypothesis. Biol Reprod 22:73-106, 1980.
6. Shukovski L, Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 135:2287-2290, 1994.
7. Murdoch WJ. Plasmin-tumour necrosis factor interaction in the ovulatory process. J Reprod Fertil Suppl 54:353-358, 1999.
8. Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459-1467, 1999.
9. Kodaman PH, Behrman HR. Endocrine-related and protein kinase C-dependent generation of superoxide by rat preovulatory follicles. Endocrinology 142:687-693, 2001.
10. Murdoch WJ. Programmed cell death in preovulatory ovine follicles. Biol Reprod 53:8-12, 1995.
11. Murdoch WJ, Townsend RS, McDonnel AC. Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis. Biol Reprod 65:1417-1424, 2001.
12. Murdoch WJ. Ovarian surface epithelium during ovulatory and anovulatory ovine estrous cycles. Anat Rec 240:322-326, 1994.
13. Murdoch WJ, Van Kirk EA. Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells. Mol Cell Endocrinol 186:61-67, 2002.
14. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford, UK: Oxford University Press, 1999.
15. Berchuck A, Carney M. Human ovarian cancer of the surface epithelium. Biochem Pharmacol 54:541-544, 1997.
16. Auersperg N, Edelson MI, Mok SC, Johnson SW, Hamilton TC. The biology of ovarian cancer. Semin Oncol 25:281-304, 1998.
17. Baker VV. The pathogenesis of epithelial ovarian cancer. J Clin Ligand Assay 21:438-441, 1998.
18. Murdoch WJ, McDonnel AC. Roles of the ovarian surface epithelium in ovulation and carcinogenesis. Reproduction 123:743-750, 2002.
19. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inference regarding pathogenesis. J Natl Cancer Inst 71:717-721, 1983.
20. Perez RP, Godwin AK, Hamilton TC, Ozols RF. Ovarian cancer biology. Semin Oncol 18:186-204, 1991.
21. Mant JWF, Vessey MP. Ovarian and endometrial cancers. Cancer Surv 19:287-307, 1994.
22. Siskind V, Green A, Bain C, Purdie D. Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology 11:106-110, 2000.
23. Laiho M, Latonen L. Cell cycle control, DNA damage checkpoints and cancer. Ann Med 35:391-397, 2003.
24. Aunoble B, Sanches R, Didier E, Bignon YJ. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int J Oncol 16:567-576, 2000.
25. Bast RC, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and future. Int J Biol Mark 13:179-187, 1998.
26. Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology 38:87-95, 2001.
27. Murdoch WJ. Metaplastic potential of p53 down-regulation in ovarian surface epithelial cells affected by ovulation. Cancer Lett 191:75-81, 2003.
28. Hamilton TC. Ovarian cancer, biology. Curr Probl Cancer 16:5-57, 1992.
29. Nahhas WA. Ovarian cancer. Current outlook on this deadly disease. Postgrad Med 102:112-120, 1997.
30. Runnebaum IB, Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 127:73-79, 2001.
31. National Research Council. Vitamin Tolerance of Animals. Washington, DC: National Academies Press, 1987.
32. Morrissey PA, Sheehy PJA. Optimal nutrition: vitamin E. Proc Nutr Soc 58:459-468, 1999.
33. Herrera E, Barbas C. Vitamin E: action, metabolism and perspectives. J Physiol Biochem 57:43-56, 2001.
34. Fairfield KM, Hankinson SE, Rosner BA, Hunter DJ, Colditz GA, Willett WC. Risk of ovarian carcinoma and consumption of vitamins A, C, and E and specific carotenoids. Cancer 92:2318-2326, 2001.
35. McCann SE, Moysich KB, Mettlin C. Intakes of selected nutrients and food groups and risk of ovarian cancer. Nutr Cancer 39:19-28, 2001.
36. Tamini RM, Lagiou P, Adami HO, Trichopoulos D. Prospects for chemoprevention of cancer. J Int Med 251:286-300, 2002.
37. Sung L, Greenberg ML, Koren G, Tomlinson GA, Tong A, Malkin D, Feldman BM. Vitamin E: the evidence for multiple roles in cancer. Nutr Cancer 46:1-14, 2003.
38. Kline K, Lawson KA, Yu WP, Sanders BG. Vitamin E and breast cancer prevention: current status and future potential. J Mammary Gland Biol Neoplasia 8:91-102, 2003.
39. de Zwart LL. Biomarkers of free radical damage: applications in experimental animals and in humans. Free Rad Biol Med 26:202-226, 1999.
40. Scaramuzzi RJ, Adams NR, Baird DT, Campbell BK, Downing JA, Findlay JK, Henderson KM, Martin GB, McNatty KP, McNeilly AS, Tsonis CG. A model for follicle selection and the determination of ovulation rate in the ewe. Reprod Fertil Dev 5:459-478, 1993.
41. Murdoch J, Van Kirk EA, Murdoch WJ. Hormonal control of urokinase plasminogen activator secretion by sheep ovarian surface epithelial cells. Biol Reprod 61:1487-1491, 1999.
42. Njeru CA, McDowell LR, Wilkinson NS, Linda SB, Williams SN, Lentz EL. Serum α-tocopherol in sheep after intramuscular injection of DL-α-tocopherol. J Anim Sci 70:2562-2567, 1992.
43. Njeru CA, McDowell LR, Wilkinson NS, Linda SB, Rojas LX, Williams SN. Serum and tissue tocopherol in sheep after intramuscular injection and(or) dietary vitamin E supplementation. J Anim Sci 72:739-745, 1994.
44. Alexander BM, Murdoch WJ, Hallford DM, Moss GE. Seasonal effects of antihistamine on mean serum concentrations of luteinizing hormone, growth hormone and prolactin in ovariectomized ewes. Anim Reprod Sci 37:15-24, 1994.
45. Dequiedt F, Kettman R, Burny A, Willems L. Nucleotide sequence of the ovine p53 tumor-suppressor cDNA and its genomic organization. DNA Seq 5:255-259, 1995.
46. Eggleston DL, Wilken C, Van Kirk EA, Slaughter RG, Ji TH, Murdoch WJ. Progesterone induces expression of endometrial messenger RNA encoding for cyclooxygenase. Prostaglandins 39:675-683, 1990.
47. Collins AR. Oxidative DNA damage, antioxidants, and cancer. Bioessays 21:238-246, 1999.
48. Grollman AP, Moriya M. Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 9:246-249, 1993.
49. Cunningham RP. DNA repair: caretakers of the genome. Curr Biol 7:576-579, 1997.
50. Robinson JM, Badwey JA. Production of active oxygen species by phagocytic leukocytes. Immunol Ser 60:159-178, 1994.
51. Cavender JL, Murdoch WJ. Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biol Reprod 39:989-997, 1988.
52. Behrman HR, Kodaman PH, Preston SL, Gao S. Oxidative stress and the ovary. J Soc Gynec Invest 8:S40-S42, 2001.
53. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol 282:C227-C241, 2002.
54. Murdoch WJ, Nix KJ, Dunn TG. Dynamics of ovarian blood supply to periovulatory follicles of the ewe. Biol Reprod 28:1001-1006, 1983.
55. O'Brien TJ, Tanimoto H, Konishi I, Gee M. More than 15 years of CA 125: what is known about the antigen, its structure and its function. Int J Biol Mark 13:188-195, 1998.
56. Yin BWT, Lloyd KO. Molecular cloning of the CA125 ovarian cancer antigen. J Biol Chem 276:27371-27375, 2001.
57. O'Brien TJ, Beard JB, Underwood LJ, Dennis RA, Santin AD, York L. The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumor Biol 22:348-366, 2001.
58. McDonnel AC, Van Kirk EA, Austin KJ, Hansen TR, Belden EL, Murdoch WJ. CA-125 expression by progestational bovine endometrium: prospective regulation and function. Reproduction 126:615-620, 2003.
59. Murdoch WJ. Proteolytic and cellular death mechanisms in ovulatory ovarian rupture. Biol Signal Recept 9:102-114, 2000.
60. Nugent D, Newton H, Gallivan L, Gosden RG. Protective effect of vitamin E on ischaemia-reperfusion injury in ovarian grafts. J Reprod Fertil 114:341-346, 1998.
61. Azzi A, Ricciarelli R, Zingg JM. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett 519:8-10, 2002.
62. Claycombe KJ, Meydani SN. Vitamin E and genome stability. Mutat Res 475:37-44, 2001.
63. Kline K, Yu W, Sanders BG. Vitamin E: mechanisms of action as tumor cell growth inhibitors. J Nutr 131:161S-163S, 2001.
64. Ricciarelli R, Zingg JM, Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J 15:2314-2325, 2001.
65. Neuzil J, Kågedal K, Andera L, Weber C, Brunk UT. Vitamin E analogs: a new class of multiple action agents with anti-neoplastic and anti-atherogenic activity. Apoptosis 7:179-187, 2002.